Brookhaven Lab made promising medical isotopes link to treating cancer
June 06, 2023 | Metallurgical Lab
There are clear benefits in having both target irradiation and hot cells for processing at one laboratory. It establishes a more efficient path for producing larger Ac-225 batch sizes by removing the logistical challenges inherent in involving multiple labs and transporting targets.
“Now we can irradiate the targets and process them right here at Brookhaven so that Ac-225 can be shipped directly to research centers,” Cutler said.
The hope is that this accelerator-produced supply of Ac-225 will advance the development of promising cancer treatments—and ultimately support the market demands of therapies that get approved.